EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of wires or leads; and SOLVE-CRT, an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
U.S. Market Performance
7D7 Days: -0.2%
3M3 Months: 12.2%
1Y1 Year: 22.4%
YTDYear to Date: 7.7%
The Communication Services sector gained 3.4% while the market remained flat over the last week. Meanwhile, the market is actually up 22% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.